frequency-domain response analysis for quantitative systems pharmacology models
TRANSCRIPT
![Page 1: Frequency-domain response analysis for quantitative systems pharmacology models](https://reader033.vdocuments.us/reader033/viewer/2022051706/587ce87e1a28ab564b8b4a63/html5/thumbnails/1.jpg)
Frequency-domain response analysis for quantitativesystems pharmacology modelsNovember 17, 2016
Pascal Schulthess
Systems PharmacologyLeiden Academic Centre for Drug Research (LACDR)Leiden University, The Netherlands
![Page 2: Frequency-domain response analysis for quantitative systems pharmacology models](https://reader033.vdocuments.us/reader033/viewer/2022051706/587ce87e1a28ab564b8b4a63/html5/thumbnails/2.jpg)
I’m an Control Engineer.
with a PhD in Theoretical Biophysics.now doing a PostDoc in Mathematical Pharmacology.
1
![Page 3: Frequency-domain response analysis for quantitative systems pharmacology models](https://reader033.vdocuments.us/reader033/viewer/2022051706/587ce87e1a28ab564b8b4a63/html5/thumbnails/3.jpg)
I’m an Control Engineer
.
with a PhD in Theoretical Biophysics.
now doing a PostDoc in Mathematical Pharmacology.
1
![Page 4: Frequency-domain response analysis for quantitative systems pharmacology models](https://reader033.vdocuments.us/reader033/viewer/2022051706/587ce87e1a28ab564b8b4a63/html5/thumbnails/4.jpg)
I’m an Control Engineer
.
with a PhD in Theoretical Biophysics
.
now doing a PostDoc in Mathematical Pharmacology.
1
![Page 5: Frequency-domain response analysis for quantitative systems pharmacology models](https://reader033.vdocuments.us/reader033/viewer/2022051706/587ce87e1a28ab564b8b4a63/html5/thumbnails/5.jpg)
A short excursion intoengineering
![Page 6: Frequency-domain response analysis for quantitative systems pharmacology models](https://reader033.vdocuments.us/reader033/viewer/2022051706/587ce87e1a28ab564b8b4a63/html5/thumbnails/6.jpg)
Mass-spring-damper system with base excitation
u
y
2
![Page 7: Frequency-domain response analysis for quantitative systems pharmacology models](https://reader033.vdocuments.us/reader033/viewer/2022051706/587ce87e1a28ab564b8b4a63/html5/thumbnails/7.jpg)
Mass-spring-damper system with base excitation
u
y
2
![Page 8: Frequency-domain response analysis for quantitative systems pharmacology models](https://reader033.vdocuments.us/reader033/viewer/2022051706/587ce87e1a28ab564b8b4a63/html5/thumbnails/8.jpg)
Mass-spring-damper system with base excitation
u
y
2
![Page 9: Frequency-domain response analysis for quantitative systems pharmacology models](https://reader033.vdocuments.us/reader033/viewer/2022051706/587ce87e1a28ab564b8b4a63/html5/thumbnails/9.jpg)
Mass-spring-damper system with base excitation
u
y
2
![Page 10: Frequency-domain response analysis for quantitative systems pharmacology models](https://reader033.vdocuments.us/reader033/viewer/2022051706/587ce87e1a28ab564b8b4a63/html5/thumbnails/10.jpg)
Mass-spring-damper system with base excitation
u
y
2
![Page 11: Frequency-domain response analysis for quantitative systems pharmacology models](https://reader033.vdocuments.us/reader033/viewer/2022051706/587ce87e1a28ab564b8b4a63/html5/thumbnails/11.jpg)
Mass-spring-damper system with base excitation
u
y
2
![Page 12: Frequency-domain response analysis for quantitative systems pharmacology models](https://reader033.vdocuments.us/reader033/viewer/2022051706/587ce87e1a28ab564b8b4a63/html5/thumbnails/12.jpg)
Mass-spring-damper system with base excitation
u
y
2
![Page 13: Frequency-domain response analysis for quantitative systems pharmacology models](https://reader033.vdocuments.us/reader033/viewer/2022051706/587ce87e1a28ab564b8b4a63/html5/thumbnails/13.jpg)
Frequency-domain response analysis
• How does a system respond to periodic inputs?
• Which input frequencies amplify/attenuate the output?
• Is there resonance?
3
![Page 14: Frequency-domain response analysis for quantitative systems pharmacology models](https://reader033.vdocuments.us/reader033/viewer/2022051706/587ce87e1a28ab564b8b4a63/html5/thumbnails/14.jpg)
Frequency-domain response analysis
• How does a system respond to periodic inputs?
• Which input frequencies amplify/attenuate the output?
• Is there resonance?
3
![Page 15: Frequency-domain response analysis for quantitative systems pharmacology models](https://reader033.vdocuments.us/reader033/viewer/2022051706/587ce87e1a28ab564b8b4a63/html5/thumbnails/15.jpg)
Frequency-domain response analysis
• How does a system respond to periodic inputs?
• Which input frequencies amplify/attenuate the output?
• Is there resonance?
3
![Page 16: Frequency-domain response analysis for quantitative systems pharmacology models](https://reader033.vdocuments.us/reader033/viewer/2022051706/587ce87e1a28ab564b8b4a63/html5/thumbnails/16.jpg)
Where’s the connection to pharmacology?
3
![Page 17: Frequency-domain response analysis for quantitative systems pharmacology models](https://reader033.vdocuments.us/reader033/viewer/2022051706/587ce87e1a28ab564b8b4a63/html5/thumbnails/17.jpg)
FdRA for QSP models
![Page 18: Frequency-domain response analysis for quantitative systems pharmacology models](https://reader033.vdocuments.us/reader033/viewer/2022051706/587ce87e1a28ab564b8b4a63/html5/thumbnails/18.jpg)
A tolerance and rebound PD model
4
![Page 19: Frequency-domain response analysis for quantitative systems pharmacology models](https://reader033.vdocuments.us/reader033/viewer/2022051706/587ce87e1a28ab564b8b4a63/html5/thumbnails/19.jpg)
A tolerance and rebound PD model
x1
u
x2
kin kout
ktol ktol
4
![Page 20: Frequency-domain response analysis for quantitative systems pharmacology models](https://reader033.vdocuments.us/reader033/viewer/2022051706/587ce87e1a28ab564b8b4a63/html5/thumbnails/20.jpg)
Response characteristic of the PD model
x1
u
x2
kin kout
ktol ktol
5
![Page 21: Frequency-domain response analysis for quantitative systems pharmacology models](https://reader033.vdocuments.us/reader033/viewer/2022051706/587ce87e1a28ab564b8b4a63/html5/thumbnails/21.jpg)
Response characteristic of the PD model
u G y
5
![Page 22: Frequency-domain response analysis for quantitative systems pharmacology models](https://reader033.vdocuments.us/reader033/viewer/2022051706/587ce87e1a28ab564b8b4a63/html5/thumbnails/22.jpg)
Response characteristic of the PD model
u G y
5
![Page 23: Frequency-domain response analysis for quantitative systems pharmacology models](https://reader033.vdocuments.us/reader033/viewer/2022051706/587ce87e1a28ab564b8b4a63/html5/thumbnails/23.jpg)
Response characteristic of the PD model
u G y
Input
u(t) = sin(ωt)
5
![Page 24: Frequency-domain response analysis for quantitative systems pharmacology models](https://reader033.vdocuments.us/reader033/viewer/2022051706/587ce87e1a28ab564b8b4a63/html5/thumbnails/24.jpg)
Response characteristic of the PD model
u G y
Input
u(t) = sin(ωt)
Output
y(t) = Asin(ωt+ φ)
5
![Page 25: Frequency-domain response analysis for quantitative systems pharmacology models](https://reader033.vdocuments.us/reader033/viewer/2022051706/587ce87e1a28ab564b8b4a63/html5/thumbnails/25.jpg)
Response characteristic of the PD model
u G y
Input
u(t) = sin(ωt)
Output
y(t) = Asin(ωt+ φ)
5
![Page 26: Frequency-domain response analysis for quantitative systems pharmacology models](https://reader033.vdocuments.us/reader033/viewer/2022051706/587ce87e1a28ab564b8b4a63/html5/thumbnails/26.jpg)
Frequency response of the PD model
x1
u
x2
kin kout
ktol ktol
Model equations
x(t) =[0 −koutktol −ktol
]x(t) +
[kin0
]u(t)
y(t) =[1 0
]x(t)
6
![Page 27: Frequency-domain response analysis for quantitative systems pharmacology models](https://reader033.vdocuments.us/reader033/viewer/2022051706/587ce87e1a28ab564b8b4a63/html5/thumbnails/27.jpg)
Frequency response of the PD model
Model equations
x(t) =[0 −koutktol −ktol
]x(t) +
[kin0
]u(t)
y(t) =[1 0
]x(t)
Transfer function
G(iω) =[1 0
] ([iω 00 iω
]−
[0 −koutktol −ktol
])−1 [kin0
]
=kin(ktol − iω)
ω2 − ktol(kout − iω)
6
![Page 28: Frequency-domain response analysis for quantitative systems pharmacology models](https://reader033.vdocuments.us/reader033/viewer/2022051706/587ce87e1a28ab564b8b4a63/html5/thumbnails/28.jpg)
Frequency response of the PD model
Model equations
x(t) =[0 −koutktol −ktol
]x(t) +
[kin0
]u(t)
y(t) =[1 0
]x(t)
Transfer function
G(iω) =[1 0
] ([iω 00 iω
]−
[0 −koutktol −ktol
])−1 [kin0
]=
kin(ktol − iω)
ω2 − ktol(kout − iω)
6
![Page 29: Frequency-domain response analysis for quantitative systems pharmacology models](https://reader033.vdocuments.us/reader033/viewer/2022051706/587ce87e1a28ab564b8b4a63/html5/thumbnails/29.jpg)
Frequency response of the PD model
Transfer function
G(iω) =[1 0
] ([iω 00 iω
]−
[0 −koutktol −ktol
])−1 [kin0
]=
kin(ktol − iω)
ω2 − ktol(kout − iω)
Magnitude
A = |G(iω)|
Phase shift
φ = argG(iω)
6
![Page 30: Frequency-domain response analysis for quantitative systems pharmacology models](https://reader033.vdocuments.us/reader033/viewer/2022051706/587ce87e1a28ab564b8b4a63/html5/thumbnails/30.jpg)
Frequency response of the PD model
Transfer function
G(iω) =kin(ktol − iω)
ω2 − ktol(kout − iω)
Magnitude
A = |G(iω)|
Phase shift
φ = argG(iω)
6
![Page 31: Frequency-domain response analysis for quantitative systems pharmacology models](https://reader033.vdocuments.us/reader033/viewer/2022051706/587ce87e1a28ab564b8b4a63/html5/thumbnails/31.jpg)
Alternative treatment scheme to optimise effect amplitude
7
![Page 32: Frequency-domain response analysis for quantitative systems pharmacology models](https://reader033.vdocuments.us/reader033/viewer/2022051706/587ce87e1a28ab564b8b4a63/html5/thumbnails/32.jpg)
Alternative treatment scheme to optimise effect amplitude
ResultTreatment every 8 hours minimises effect amplitude.
7
![Page 33: Frequency-domain response analysis for quantitative systems pharmacology models](https://reader033.vdocuments.us/reader033/viewer/2022051706/587ce87e1a28ab564b8b4a63/html5/thumbnails/33.jpg)
Alternative treatment scheme to optimise effect amplitude
ResultTreatment every 24 hours maximises effect amplitude.
7
![Page 34: Frequency-domain response analysis for quantitative systems pharmacology models](https://reader033.vdocuments.us/reader033/viewer/2022051706/587ce87e1a28ab564b8b4a63/html5/thumbnails/34.jpg)
FdRA allows for
analyticaloptimisation of dosing frequency.
7
![Page 35: Frequency-domain response analysis for quantitative systems pharmacology models](https://reader033.vdocuments.us/reader033/viewer/2022051706/587ce87e1a28ab564b8b4a63/html5/thumbnails/35.jpg)
Influence of model parameters
8
![Page 36: Frequency-domain response analysis for quantitative systems pharmacology models](https://reader033.vdocuments.us/reader033/viewer/2022051706/587ce87e1a28ab564b8b4a63/html5/thumbnails/36.jpg)
Influence of model parameters
8
![Page 37: Frequency-domain response analysis for quantitative systems pharmacology models](https://reader033.vdocuments.us/reader033/viewer/2022051706/587ce87e1a28ab564b8b4a63/html5/thumbnails/37.jpg)
Influence of model parameters
8
![Page 38: Frequency-domain response analysis for quantitative systems pharmacology models](https://reader033.vdocuments.us/reader033/viewer/2022051706/587ce87e1a28ab564b8b4a63/html5/thumbnails/38.jpg)
FdRA highlights how
parametersinfluence treatment scheme.
8
![Page 39: Frequency-domain response analysis for quantitative systems pharmacology models](https://reader033.vdocuments.us/reader033/viewer/2022051706/587ce87e1a28ab564b8b4a63/html5/thumbnails/39.jpg)
Potential of FdRA in QSP
![Page 40: Frequency-domain response analysis for quantitative systems pharmacology models](https://reader033.vdocuments.us/reader033/viewer/2022051706/587ce87e1a28ab564b8b4a63/html5/thumbnails/40.jpg)
Frequency Dependence of Osmo-Adaptation in yeast
Mettetal et al., Science (2008) & Muzzey et al., Cell (2009) 9
![Page 41: Frequency-domain response analysis for quantitative systems pharmacology models](https://reader033.vdocuments.us/reader033/viewer/2022051706/587ce87e1a28ab564b8b4a63/html5/thumbnails/41.jpg)
Frequency Dependence of Osmo-Adaptation in yeast
Mettetal et al., Science (2008) & Muzzey et al., Cell (2009) 9
![Page 42: Frequency-domain response analysis for quantitative systems pharmacology models](https://reader033.vdocuments.us/reader033/viewer/2022051706/587ce87e1a28ab564b8b4a63/html5/thumbnails/42.jpg)
Frequency dependence of osmo-adaptation in yeast
Mettetal et al., Science (2008) & Muzzey et al., Cell (2009) 10
![Page 43: Frequency-domain response analysis for quantitative systems pharmacology models](https://reader033.vdocuments.us/reader033/viewer/2022051706/587ce87e1a28ab564b8b4a63/html5/thumbnails/43.jpg)
Frequency dependence of osmo-adaptation in yeast
Mettetal et al., Science (2008) & Muzzey et al., Cell (2009) 10
![Page 44: Frequency-domain response analysis for quantitative systems pharmacology models](https://reader033.vdocuments.us/reader033/viewer/2022051706/587ce87e1a28ab564b8b4a63/html5/thumbnails/44.jpg)
Frequency dependence of osmo-adaptation in yeast
− Mapk signalling& nuclear import
Hog1-independentmechanisms
Hog1-dependentmechanisms
+
Glycerolaccumulation
Osmext Hog1∗
Osmint
Mettetal et al., Science (2008) & Muzzey et al., Cell (2009) 10
![Page 45: Frequency-domain response analysis for quantitative systems pharmacology models](https://reader033.vdocuments.us/reader033/viewer/2022051706/587ce87e1a28ab564b8b4a63/html5/thumbnails/45.jpg)
FdRA enables
model identificationfrom experiments.
10
![Page 46: Frequency-domain response analysis for quantitative systems pharmacology models](https://reader033.vdocuments.us/reader033/viewer/2022051706/587ce87e1a28ab564b8b4a63/html5/thumbnails/46.jpg)
Conclusion & outlook
![Page 47: Frequency-domain response analysis for quantitative systems pharmacology models](https://reader033.vdocuments.us/reader033/viewer/2022051706/587ce87e1a28ab564b8b4a63/html5/thumbnails/47.jpg)
Conclusion
Frequency-domain response analysis
• allows for analytical dosing frequency optimisation
• highlights how parameters influence treatment scheme
• enables model identification from experiments
11
![Page 48: Frequency-domain response analysis for quantitative systems pharmacology models](https://reader033.vdocuments.us/reader033/viewer/2022051706/587ce87e1a28ab564b8b4a63/html5/thumbnails/48.jpg)
Conclusion
Frequency-domain response analysis
• allows for analytical dosing frequency optimisation
• highlights how parameters influence treatment scheme
• enables model identification from experiments
11
![Page 49: Frequency-domain response analysis for quantitative systems pharmacology models](https://reader033.vdocuments.us/reader033/viewer/2022051706/587ce87e1a28ab564b8b4a63/html5/thumbnails/49.jpg)
Conclusion
Frequency-domain response analysis
• allows for analytical dosing frequency optimisation
• highlights how parameters influence treatment scheme
• enables model identification from experiments
11
![Page 50: Frequency-domain response analysis for quantitative systems pharmacology models](https://reader033.vdocuments.us/reader033/viewer/2022051706/587ce87e1a28ab564b8b4a63/html5/thumbnails/50.jpg)
Conclusion
Frequency-domain response analysis
• allows for analytical dosing frequency optimisation
• highlights how parameters influence treatment scheme
• enables model identification from experiments
11
![Page 51: Frequency-domain response analysis for quantitative systems pharmacology models](https://reader033.vdocuments.us/reader033/viewer/2022051706/587ce87e1a28ab564b8b4a63/html5/thumbnails/51.jpg)
Outlook
Open questions
• Which systems give rise to which response behaviour?
• Can FdRA identify model structures from experiments?
• Is FdRA able to suggest (better) treatment schedules?
• Can FdRA be extended to allow combinatory treatments?
• How to incorporate FdRA into clinical practice?
12
![Page 52: Frequency-domain response analysis for quantitative systems pharmacology models](https://reader033.vdocuments.us/reader033/viewer/2022051706/587ce87e1a28ab564b8b4a63/html5/thumbnails/52.jpg)
Outlook
Open questions
• Which systems give rise to which response behaviour?
• Can FdRA identify model structures from experiments?
• Is FdRA able to suggest (better) treatment schedules?
• Can FdRA be extended to allow combinatory treatments?
• How to incorporate FdRA into clinical practice?
12
![Page 53: Frequency-domain response analysis for quantitative systems pharmacology models](https://reader033.vdocuments.us/reader033/viewer/2022051706/587ce87e1a28ab564b8b4a63/html5/thumbnails/53.jpg)
Outlook
Open questions
• Which systems give rise to which response behaviour?
• Can FdRA identify model structures from experiments?
• Is FdRA able to suggest (better) treatment schedules?
• Can FdRA be extended to allow combinatory treatments?
• How to incorporate FdRA into clinical practice?
12
![Page 54: Frequency-domain response analysis for quantitative systems pharmacology models](https://reader033.vdocuments.us/reader033/viewer/2022051706/587ce87e1a28ab564b8b4a63/html5/thumbnails/54.jpg)
Outlook
Open questions
• Which systems give rise to which response behaviour?
• Can FdRA identify model structures from experiments?
• Is FdRA able to suggest (better) treatment schedules?
• Can FdRA be extended to allow combinatory treatments?
• How to incorporate FdRA into clinical practice?
12
![Page 55: Frequency-domain response analysis for quantitative systems pharmacology models](https://reader033.vdocuments.us/reader033/viewer/2022051706/587ce87e1a28ab564b8b4a63/html5/thumbnails/55.jpg)
Outlook
Open questions
• Which systems give rise to which response behaviour?
• Can FdRA identify model structures from experiments?
• Is FdRA able to suggest (better) treatment schedules?
• Can FdRA be extended to allow combinatory treatments?
• How to incorporate FdRA into clinical practice?
12
![Page 56: Frequency-domain response analysis for quantitative systems pharmacology models](https://reader033.vdocuments.us/reader033/viewer/2022051706/587ce87e1a28ab564b8b4a63/html5/thumbnails/56.jpg)
Outlook
Open questions
• Which systems give rise to which response behaviour?
• Can FdRA identify model structures from experiments?
• Is FdRA able to suggest (better) treatment schedules?
• Can FdRA be extended to allow combinatory treatments?
• How to incorporate FdRA into clinical practice?
12
![Page 57: Frequency-domain response analysis for quantitative systems pharmacology models](https://reader033.vdocuments.us/reader033/viewer/2022051706/587ce87e1a28ab564b8b4a63/html5/thumbnails/57.jpg)
Acknowledgements
• Piet Hein van der Graaf (@certara, @lacdr.leidenuniv)
• James Yates (@astrazeneca)
• Teun Post (@lapp, @lacdr.leidenuniv)
• Vivi Rottschäfer (@math.leidenuniv)
13